Invasive lobular carcinoma
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer after invasive ductal carcinoma (IDC). It is characterized by cancer cells that have spread from the lobules where they originated into the surrounding breast tissue.
Epidemiology[edit | edit source]
ILC accounts for approximately 10% of all breast cancers. It is more common in older women, with the majority of cases occurring in women over the age of 55.
Pathophysiology[edit | edit source]
In ILC, cancer cells originate in the milk-producing lobules and then invade the surrounding breast tissue. These cells can also spread to other parts of the body through the lymphatic system and the bloodstream. Unlike IDC, ILC tends to occur in multiple areas in the breast and is often bilateral, affecting both breasts.
Clinical Presentation[edit | edit source]
The symptoms of ILC may be less obvious than those of IDC. The most common symptom is a change in the texture of the breast tissue, often described as a thickening or fullness in one part of the breast. Other symptoms can include a newly inverted nipple or skin changes such as dimpling or puckering.
Diagnosis[edit | edit source]
Diagnosis of ILC can be more challenging than other types of breast cancer due to its subtle symptoms and the fact that it often does not form a distinct lump. It may not be detected on a mammogram and may require additional imaging tests such as an ultrasound or MRI. A definitive diagnosis is made through a biopsy of the suspicious tissue.
Treatment[edit | edit source]
The treatment for ILC is similar to that for other types of breast cancer and may include surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapies. The choice of treatment depends on the stage of the cancer, the patient's overall health, and their personal preferences.
Prognosis[edit | edit source]
The prognosis for ILC is generally similar to that for IDC when detected and treated at the same stage. However, because ILC is often diagnosed at a later stage due to its subtle symptoms, the overall survival rate may be slightly lower.
See Also[edit | edit source]
- Breast cancer
- Invasive ductal carcinoma
- Lobules of the mammary gland
- Lymphatic system
- Mammography
- Ultrasound
- Magnetic resonance imaging
- Biopsy
- Radiation therapy
- Chemotherapy
- Hormone therapy
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD